AHSG and metabolic dysfunction-associated steatotic liver disease: We did so based on the preliminary finding that subgroup analysis had failed to identify significant differences (in term of demographic and metabolic variables, Fetuin-A levels and NAFLD prevalence) among patients with carotid artery disease versus lower extremity artery disease and atherosclerotic aortic aneurysm (data not shown).